Former college swimmer Riley Gaines repeatedly mocked Rep. Alexandria Ocasio-Cortez, D-N.Y., on social media on Thursday ...
Kronos Bio has given up on its only drug in clinical trials after some patients suffered neurological problems like ...
Secures $3.2m in PIPE Financing -- $50m Term Sheet Obtained for Available Financing under Equity Line of Credit - BOSTON and ...
"AOC removing the pronouns from her bio is a hell of a vibe shift," one social media user posted. X's community notes, ...
The final battle was waged last week when President-elect Donald Trump won victory. As some conservatives explain it, the ...
BridgeBio Pharma’s acoramidis shows improved survival data, boosting approval chances. Read why BBIO stock could see gains if ...
On Oct. 15, Modifi Bio, a Yale-based biotech company, closed an acquisition deal with Merck, an American pharmaceutical ...
The European Commission is asking biopharma and manufacturing companies about their reaction to Novo ...
The primary contractor for the project will be appointed next week. Keturah completes infrastructure work on Dubai’s first ...
Sensei Biotherapeutics is laying off 46% of its workforce as the cancer-focused biotech looks to preserve cash to take its ...
Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of ...
SOMERVILLE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (NASDAQ: BLUE) ("bluebird bio" or the "Company") today reported third quarter results and business highlights for the quarter ended September ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback